» Authors » Jennifer H MacLachlan

Jennifer H MacLachlan

Explore the profile of Jennifer H MacLachlan including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 34
Citations 813
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
MacLachlan J, Allard N, Tran L, Savage A, Adamson E, Price V, et al.
Aust J Prim Health . 2024 Dec; 30. PMID: 39666448
Background Diagnosis is essential for engagement in care for chronic hepatitis B (CHB) and chronic hepatitis C (CHC), however, many Australians remain undiagnosed, especially for CHB. Primary care represents an...
2.
MacLachlan J, Romero N, Allard N, Rowe S, Cowie B
J Gastroenterol Hepatol . 2024 Aug; 39(11):2377-2385. PMID: 39104039
Background And Aim: Pregnancy is a key setting for engagement in chronic hepatitis B (CHB) care, due to the implications for transmission to the infant and antenatal diagnosis representing an...
3.
Abbott M, MacLachlan J, Romero N, Matthews N, Higgins N, Lee A, et al.
Euro Surveill . 2024 Jul; 29(29). PMID: 39027939
BackgroundActive follow-up of chronic hepatitis C notifications to promote linkage to care is a promising strategy to support elimination.AimThis pilot study in Victoria, Australia, explored if the Department of Health...
4.
Hosking K, Binks P, de Santis T, Wilson P, Gurruwiwi G, Bukulatjpi S, et al.
Lancet Reg Health West Pac . 2024 Jul; 48:101116. PMID: 38966601
Background: The Northern Territory (NT) has the highest prevalence of chronic hepatitis B (CHB) in Australia. The Hep B PAST program aims to improve health outcomes for people living with...
5.
MacLachlan J, Abbott M, Jones T, Sheils S, Richmond J
Intern Med J . 2024 Apr; 54(4):695-696. PMID: 38637279
No abstract available.
6.
Snow K, MacLachlan J, Rowe S, Higgins N, Cowie B
Intern Med J . 2024 Mar; 54(7):1146-1154. PMID: 38504432
Background: Highly effective hepatitis C therapies are available in Australia. However, people living with hepatitis C face various barriers to accessing care and treatment. Aims: To identify gaps in the...
7.
Goldsmith J, Vu C, Zhu Z, MacLachlan J, Thomson T, Campbell P, et al.
Int J Infect Dis . 2024 Feb; 141:106969. PMID: 38387705
Objectives: To quantify the associations between invasive group A streptococcal disease (iGAS) incidence and influenza, varicella, and chronic hepatitis C virus (HCV). Methods: We used individual-level linked data of iGAS...
8.
Mnatzaganian G, MacLachlan J, Allard N, Brown C, Rowe S, Cowie B
J Gastroenterol Hepatol . 2023 Mar; 38(6):976-983. PMID: 36866537
Background And Aim: This study aimed to assess utilization of health-care services in people with decompensated cirrhosis (DC) or hepatocellular carcinoma (HCC) and a "late diagnosis" of hepatitis B or...
9.
McCulloch K, Romero N, Allard N, MacLachlan J, Cowie B
Aust N Z J Public Health . 2023 Jan; 47(1):100011. PMID: 36638581
Objective: Investigate the cascade of care for chronic hepatitis B (CHB) and estimate impacts of increasing treatment uptake on attributable burden, according to jurisdiction. Methods: A mathematical model of CHB...
10.
Tu T, Rodrigo C, Strasser S, Bowden D, MacLachlan J, Drummer H
Viruses . 2021 Sep; 13(9). PMID: 34578419
Viral hepatitis remains one of the most significant health issues globally, directly responsible for over 1 million deaths each year and affecting almost 300 million people around the world. Scientific...